Stockscreener 앱 받기
7.1114
4.25%
0.2914
전일 마감가:
$6.82
열려 있는:
$6.81
하루 거래량:
944.61K
Relative Volume:
0.40
시가총액:
$2.64B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-14.82
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
-3.66%
1개월 성능:
+4.41%
6개월 성능:
+33.40%
1년 성능:
-6.20%
1일 변동 폭
$6.77
$7.195
1주일 범위
$6.66
$7.44
52주 변동 폭
$4.25
$8.685
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
BHC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
7.115 | 2.53B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
118.39 | 52.03B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.51 | 45.40B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.64 | 42.13B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.71 | 34.19B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
484.33 | 20.88B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health’s Slow Rebuild Faces New Scrutiny After Lombard Odier Cuts Its Stake - The Motley Fool
Stock Recap: How Bausch Health Companies Inc stock benefits from global expansionJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - BỘ NỘI VỤ
Barclays Initiates Coverage of Bausch Health Companies (BHC) with Equal-Weight Recommendation - Nasdaq
BHC: Barclays Initiates Coverage with Equal-Weight Rating | BHC Stock News - GuruFocus
Bausch Health Cos Inc. $BHC is Goldentree Asset Management LP's Largest Position - MarketBeat
Bausch Health Companies Inc Announces Early Exchange Offer Results - TradingView
Bausch Health (NYSE:BHC) expects $1.6 billion of new 2032 notes in senior debt exchange - Stock Titan
Bausch Health Announces Early Exchange Offer Results for Exchange Offers - Yahoo Finance
Ophthalmic Drugs Market Size to Cross USD 62.74 Billion by 2032, Driven by Advances in Eye Care Treatments and Rising Global Vision Disorders - GlobeNewswire Inc.
Why Investors Shouldn't Be Surprised By Bausch Health Companies Inc.'s (NYSE:BHC) Low P/S - 富途牛牛
Bausch Health ticks higher following large director stock purchase - MSN
Is Bausch Health Companies Inc. (BVF) stock a buy before earnings resultsOptions Play & Free Community Supported Trade Ideas - Newser
Will Bausch Health Companies Inc. (BVF) stock profit from AI boomMarket Performance Summary & Accurate Intraday Trading Signals - Newser
Will Bausch Health Companies Inc. stock outperform growth indexesQuarterly Profit Report & Daily Growth Stock Tips - Newser
Can Bausch Health Companies Inc. stock sustain breakout momentumBond Market & Real-Time Stock Entry Alerts - Newser
Will Bausch Health Companies Inc. (BVF) stock sustain uptrend momentum2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
Why Bausch Health Companies Inc. stock could rally strongly2025 Buyback Activity & Consistent Profit Focused Trading Strategies - Newser
Published on: 2025-12-04 04:20:11 - Newser
Is Bausch Health Companies Inc. stock resilient to inflation2025 Sector Review & AI Powered Market Entry Ideas - Newser
Is Bausch Health Companies Inc. stock a good hedge against inflation2025 Bull vs Bear & Smart Money Movement Alerts - Newser
John Paulson's Strategic Acquisition in Bausch Health Companies Inc. - GuruFocus
What valuation ratios show for Bausch Health Companies Inc. stockWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Is Bausch Health Companies Inc. (BVF) stock supported by strong fundamentalsMarket Rally & Long-Term Safe Investment Ideas - Newser
Why pension funds invest in Bausch Health Companies Inc. (BVF) stock2025 Momentum Check & Weekly Breakout Watchlists - Newser
Why Bausch Health Companies Inc. stock remains top ratedEarnings Miss & AI Forecast Swing Trade Picks - Newser
Assessing Bausch Health Companies (NYSE:BHC) Valuation After a 13% YTD Decline and Recent Bounce - Sahm
BHC Stock Up as Solta Acquires Shibo's Aesthetics Distribution Business - cnhinews.com
Bausch Health Companies to Present at Cowen Annual Health Care Conference - ACCESS Newswire
Bausch Health Companies (BHC) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Bausch Health Cos (NYSE:BHC) Shares Gap UpHere's Why - MarketBeat
Transcript : Bausch Health Companies Inc. Presents at Evercore 8th Annual Healthcare Conference, Dec-02-2025 10 - marketscreener.com
Is There Now an Opportunity in Bausch Health Companies After Recent Debt Restructuring Developments? - Yahoo Finance
How higher bond yields impact Bausch Health Companies Inc. (BVF) stockJobs Report & Short-Term Swing Trade Alerts - Newser
Why analysts maintain buy rating on Bausch Health Companies Inc. (BVF) stockWeekly Volume Report & High Yield Equity Trading Tips - Newser
Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Globe and Mail
Bausch Health’s Intriguing Market Moves - StocksToTrade
Why Bausch Health Companies Stock Rocketed 11% Higher Today - The Motley Fool
Bausch Health completes acquisition of Chinese aesthetics distributor By Investing.com - Investing.com Australia
Why Are Shares Of Bausch Health Up Today? - Benzinga
Stocks in play: Bausch Health Companies Inc. - The Globe and Mail
Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis - ACCESS Newswire
Director buying at Bausch Health Companies (BHC) - The Globe and Mail
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.31%
0.66%
자본화:
|
볼륨(24시간):